Form 8-K AVITA Medical, Inc. For: May 13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
BofA Securities Reiterates Buy Rating on Avita Medical Ltd. (RCEL)
May 14, 2024 8:48 AM EDTBofA Securities analyst Lyanne Harrison reiterated a Buy rating and $21.00 price target on Avita Medical Ltd. (NASDAQ: RCEL).
The analyst comments "We reiterate our Buy; PO unchanged at US$21/A$6. We expect AVITA will gain momentum as the year progresses, driven by short term... More
